DUBLIN, Dec. 20, 2023 /PRNewswire/ -- The "Structural Heart Occlusion Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.

The report visualizes quantitative market trends within Cardiovascular Devices therapeutic area.

Congenital Heart Disease (CHD) is structural heart defects ranging in severity that are present at birth. Atrial septal defect (ASD) and ventricular septal defect (VSD) are the two structural abnormalities. Atrial septal defect, or ASD, is caused by a deficiency in the atrial septum leading to a failure of overlap resulting in a hole in the atrial septum. Ventricular septal defect, or VSD, occurs during pregnancy due to deficiencies in the septum that separates the left and right ventricles leading to a hole in the septum. Occluder devices are recommended for the treatment of atrial septal defects (ASD) and ventricular septal defects (VSD). This device releases a self-expandable nitinol mesh that prevents blood flow through the atrial hole. Over time, heart tissue develops over the nitinol mesh to fully occlude the defect.

Key Inclusions of the market model are -

Currently marketed Structural Heart Occlusion Devices market and evolving competitive landscape -

• Insightful review of the key industry trends.

• Annualized total Structural Heart Occlusion Devices market revenue by segment and market outlooks from 2015-2033.

• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition the analysts provide unique country specific insights on the market.

• SWOT analysis for Structural Heart Occlusion Devices market.

• Competitive dynamics insights and trends provided Structural Heart Occlusion Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.

• Country specific reimbursement policies.

• Country specific medtech regulatory landscape.

Company Coverage:

• Abbott Laboratories

• AtriCure

• Boston Scientific

• Lifetech Scientific

• Occlutech

• PFM medical

• W. L. Gore & Associates

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.